Fanny Lanternier

17.1k citations
317 papers · 12.8k · 5 hit papers · h-index 58

Impact in

    • Antifungal resistance and susceptibility
    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
  • Microbiology top 0.5%

Papers in

    • Antifungal resistance and susceptibility 134
    • SARS-CoV-2 and COVID-19 Research 14
    • COVID-19 Clinical Research Studies 7
    • HIV/AIDS drug development and treatment 6
    • Immunodeficiency and Autoimmune Disorders 50
    • Mast cells and histamine 7

Fanny Lanternier

291 papers receiving 12.4k citations

Fanny Lanternier's Hit Papers

Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study 2023 · 106 citations
1060+4+9Years since publication4008001.2k

Peers

Fanny Lanternier
Comparison fields: 5 of 141
  • Infectious Diseases 7.3k
  • Microbiology 190
  • Immunology 1.9k
  • Epidemiology 2.1k
  • Clinical Biochemistry 181
Replace Françoise Dromer with:
Françoise Dromer France
Katrien Lagrou Belgium
Márcio Nucci Brazil
Barbara Dudley Alexander United States
Adilia Warris Netherlands
John W. Baddley United States
Nina Khanna Switzerland
Annelies Verbon Netherlands
Christopher C. Kibbler United Kingdom
Francisco M. Marty United States
Fanny Lanternier relative to Françoise Dromer France Françoise Dromer's profile →
Citations per field
00.5×1.5×2.1×
Françoise Dromer · 1×
Citations per year

Countries citing papers authored by Fanny Lanternier

Since Specialization
Citations

This map shows the geographic impact of Fanny Lanternier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Lanternier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Lanternier more than expected).

Fields of papers citing papers by Fanny Lanternier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanny Lanternier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Lanternier. The network helps show where Fanny Lanternier may publish in the future.

Co-authors

The 25 scholars most cited alongside Fanny Lanternier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fanny Lanternier Line = papers co-authored together Fanny Lanternier links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 317 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
Hit paper breakdown →
20191223
2
ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013
Hit paper breakdown →
2014708
3
A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007)
Hit paper breakdown →
2012426
4
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others
Hit paper breakdown →
2014425
5 2009346
6 2013327
7 2012290
8 2014284
9 2017239
10 2012226
11 2013182
12 2010175
13 2015175
14 2012174
15 2021169
16 2017160
17 2008148
18 2022145
19 2010144
20 2015141

About Fanny Lanternier

Fanny Lanternier is a scholar working on Infectious Diseases, Immunology, Epidemiology, Parasitology and Endocrinology, having authored 317 papers that have together received 12.8k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (134 papers), Immunodeficiency and Autoimmune Disorders (50 papers), Fungal Infections and Studies (41 papers), SARS-CoV-2 and COVID-19 Research (14 papers), Nail Diseases and Treatments (8 papers), Mast cells and histamine (7 papers), COVID-19 Clinical Research Studies (7 papers) and HIV/AIDS drug development and treatment (6 papers). The work is most often cited by research in Infectious Diseases (7.3k citations), Microbiology (190 citations), Immunology (1.9k citations), Epidemiology (2.1k citations) and Clinical Biochemistry (181 citations). Fanny Lanternier has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Olivier Lortholary, Marie‐Elisabeth Bougnoux, Marc Lecuit, Éric Dannaoui, Dea Garcia‐Hermoso, Anne Puel, Françoise Dromer, Dounia Bitar, Caroline Elie and Felipe Suárez. Their work appears in journals such as Clinical Microbiology and Infection, Clinical Infectious Diseases, Journal of Clinical Immunology, Medical Mycology and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact